ImageneBio, Inc. (IMA) is a biotechnology company listed on NASDAQ.
Latest reported IMA revenue for 2025-12-31 was $800.0K. Net income was -$45.3M. IMA currently screens at market cap $64.7M.
Use this IMA page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the IMA quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the IMA SEC filings page. Lician reads the product cache first so this HTML stays unique to ImageneBio, Inc. even when a live quote feed is slow.
Latest cached year on this hub. Full IMA income, balance, and cash tables.